May 8, 2017. We support the efforts of the U.S. Preventive Services Task Force (USPSTF) to re-evaluate its recommendations in light of new research regarding prostate cancer screening that provides new insights into its benefits and risks.
Read More »On Health Policy
NCHR Testimony to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria on Animal Antibiotics
May 4, 2017. We support efforts by federal agencies to reduce unnecessary exposures to antibiotics. Reducing unnecessary exposure reduces antibiotic resistance, and thus preserves the use of these antibiotics for animal and human health.
Read More »NCHR Testimony at FDA Meeting on Developing Antibiotics for Bacteria That Rarely Cause Infection
Stephanie Fox-Rawlings, April 13 2017: At an FDA meeting, NCHR explained that developing new antibiotics for rare, low-risk bacteria could do more harm than good by exposing patients to unnecessary side effects, increasing the chances of drug-resistant infections, and diverting resources away from treatments that are truly needed.
Read More »NCHR Comment on the USPSTF’s Draft Recommendations for Vision Screening in Young Children
March 27, 2017. NCHR supports USPSTF’s draft recommendation for vision screening in young children as well as their broader efforts to improve the health of all Americans by making evidence-based recommendations about clinical preventive services. As more information becomes available, we encourage the provision of additional recommendations about procedures that improve the benefits of vision tests for children and their families.
Read More »NCHR Comment on the USPSTF’s Draft Recommendations for HIV Infection Screening in Pregnant Women
March 22, 2017. We strongly support USPSTF’s ongoing effort to provide screening guidances based on quality, up-to-date scientific studies. We recommend a very careful selection of exclusion populations and studies in order to have a thorough review that allows the USPSTF to develop the most informed recommendations possible.
Read More »